[HTML] from jurology.comG Sonpavde, MM Khan, SP Lerner, RS Svatek… - The Journal of …, 2011 - Elsevier Overall 2-year/3-year disease-free survival was 0.63/0.57 and 5-year overall survival was 0.47. The overall agreement between 2-year disease-free survival and 5-year overall survival was 79%, and between 3-year disease-free survival and 5-year overall survival was 81%. ... Cited by 2 - Related articles - All 5 versions
AM Brewster, P Thompson, AA Sahin, KA Do… - Cancer Prevention …, 2011 - AACR ... on Disease-freeSurvival AM Brewster1, P. Thompson2, AA Sahin3, K. Do4, M. Edgerton3, JL Murray5, S. ... Cox proportional modeling was used to estimate the effect of method of tumor detection on disease-freesurvival after adjusting for age, stage and the CNIs. ...
SE Delacroix Jr, BF Chapin, JJ Chen… - The Journal of …, 2011 - Elsevier A total of 2,521 patients with nonmetastatic renal cell carcinoma (T any N any M0) of any histological subtype treated with nephrectomy were identified between 1995 and 2009. Pathological regional node positive disease in the absence of clinically detectable metastases (T any N 1-2 M0) ... Cited by 2
DP Steinfort, J Grieve, ML Hibbs, GP Anderson… - Human Pathology, 2011 - Elsevier Sarcoidal reactions occurring in regional lymph nodes of patients with non–small cell lung carcinoma appear to be limited to patients with stage I disease. The prognostic significance of this remains unknown. Such reactions are thought to represent a cell-mediated antitumor response ...
PC Lee, FM Mirza, JL Port, BM Stiles… - The Journal of Thoracic …, 2011 - Elsevier From 1988 to 2009, 465 of 500 patients underwent complete resection for esophageal carcinoma. Median follow-up for living patients was 49 months; 197 patients (42.4%) had recurrence, leading to 175 patients dying of cancer and 22 patients living with recurrent ... Related articles - All 5 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
